We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+13.86%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$450M
AUM Growth
+$44.2M
Cap. Flow
+$6.33M
Cap. Flow %
1.41%
Top 10 Hldgs %
82.16%
Holding
81
New
7
Increased
6
Reduced
2
Closed
4

Top Buys

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$4.88M
2
CUE icon
Cue Biopharma
CUE
+$2.38M
3
PROF
Profound Medical
PROF
+$1.27M
4
MDXH icon
MDxHealth
MDXH
+$1.26M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.1M

Top Sells

Rank Stock Value
1
DRRX
DURECT Corp
DRRX
+$6.57M
2
YEXT icon
Yext
YEXT
+$274K
3
EQRX
EQRx, Inc. Common Stock
EQRX
+$11.1K
4
EQRXW
EQRx, Inc. Warrant
EQRXW
+$8.02K
5
LLYVK icon
Liberty Live Group Series C
LLYVK
+$68

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.98%
2 Miscellaneous 20.63%
3 Healthcare 20.15%
4 Industrials 14.66%
5 Materials 10.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LBTYK icon
26
Liberty Global Class C
LBTYK
$3.56B
$1.3M 0.29%
69,618
– –
ONDS icon
27
Ondas Inc
ONDS
$4.51B
$1.19M 0.26%
775,000
– –
SPY icon
28
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$1.17M 0.26%
+2,470
New +$1.1M
PROF
29
Profound Medical
PROF
$250M
$1.13M 0.25%
+133,333
New +$1.27M
MXCT icon
30
MaxCyte
MXCT
$126M
$1.12M 0.25%
250,000
– –
RCAT icon
31
Red Cat Holdings
RCAT
$1.3B
$880K 0.2%
+1,000,000
New +$858K
LSXMA
32
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$695K 0.15%
24,197
– –
DMAC icon
33
DiaMedica Therapeutics
DMAC
$345M
$631K 0.14%
222,317
– –
ICCC icon
34
ImmuCell
ICCC
$90.3M
$517K 0.11%
101,594
– –
LLYVK icon
35
Liberty Live Group Series C
LLYVK
$9.53B
$516K 0.11%
13,802
-2
-0% -$68
RTX icon
36
RTX Corp
RTX
$285B
$505K 0.11%
6,000
– –
LBTYA icon
37
Liberty Global Class A
LBTYA
$3.64B
$409K 0.09%
22,989
– –
ARKOW
38
DELISTED
ARKO Corp Warrant
ARKOW
$367K 0.08%
333,333
– –
CARR icon
39
Carrier Global
CARR
$48.5B
$345K 0.08%
6,000
– –
LHX icon
40
L3Harris
LHX
$48.9B
$337K 0.07%
1,600
– –
PYPL icon
41
PayPal
PYPL
$45.9B
$325K 0.07%
5,300
– –
CRIS icon
42
Curis
CRIS
$3.61M
$319K 0.07%
1,250
– –
RGF
43
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
$304K 0.07%
+16,667
New +$413K
OTIS icon
44
Otis Worldwide
OTIS
$27.3B
$268K 0.06%
3,000
– –
LLYVA icon
45
Liberty Live Group Series A
LLYVA
$9.19B
$221K 0.05%
6,047
-2
-0% -$66
GPCR icon
46
Structure Therapeutics
GPCR
$3.38B
$204K 0.05%
+5,000
New +$287K
PHYS icon
47
Sprott Physical Gold
PHYS
$16B
$200K 0.04%
12,540
– –
LGF.B
48
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$167K 0.04%
16,413
– –
HLTH
49
DELISTED
Cue Health Inc. Common Stock
HLTH
$163K 0.04%
1,000,000
– –
CDNS icon
50
Cadence Design Systems
CDNS
$93.7B
$143K 0.03%
525
– –
1
2
3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return

Bleichroeder LP's Q4 2023 Portfolio in Review

As of Q4 2023, Bleichroeder LP held 81 positions worth $450M, up 11% from $406M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Bleichroeder LP's Q4 2023 filing shows 7 new, 6 increased, 2 reduced and 4 closed positions. Its largest new stake was Profound Medical: 133,333 shares worth $1.13M. The largest sale was DURECT Corp, an estimated $6.57M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.

  • Bleichroeder LP's largest Q4 2023 buy was Profound Medical: 133,333 shares worth $1.13M.
  • Bleichroeder LP added most to bluebird bio in Q4 2023, an estimated $4.88M increase.
  • Bleichroeder LP's biggest Q4 2023 reduction was Liberty Live Group Series C, cutting an estimated $68.
  • Bleichroeder LP fully exited DURECT Corp in Q4 2023, selling an estimated $6.57M.
  • Bleichroeder LP's ten largest holdings make up 82% of its $450M portfolio in Q4 2023.
  • Bleichroeder LP opened 7 new positions and closed 4 in Q4 2023.
  • Bleichroeder LP's portfolio value rose 11% quarter-over-quarter to $450M.

Based on Bleichroeder LP's 13F filing for Q4 2023, filed 12 Feb 2024.